Order intake has stalled
Revenue still runs off the backlog, but order intake is falling away. Visit numbers and hit rate are dropping while sales costs keep rising.
I take commercial leadership and point sales at the companies with a demonstrable investment need — instead of visit routines and account maintenance. In parallel I move sales management onto figures that hold up.
CHIRON: order intake +40%, hit rate +20%
